APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-invasive Prenatal Paternity Testing(NIPPT)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook and Growth Opportunities 2026

25 December 2025195 pages

Choose your research edition.

Industry ResearchNon-invasive Prenatal Paternity Testing(NIPPT) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-invasive Prenatal Paternity Testing(NIPPT) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-invasive Prenatal Paternity Testing(NIPPT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-invasive Prenatal Paternity Testing(NIPPT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-invasive Prenatal Paternity Testing(NIPPT) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-invasive Prenatal Paternity Testing(NIPPT) market include BGI Genomics, Ultrasound Plus, Roche company, PrenatalGeneticslab, Natera, LabCorp, International Biosciences, Illumina and Express Diagnostic Center (EDC), among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-invasive Prenatal Paternity Testing(NIPPT) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-invasive Prenatal Paternity Testing(NIPPT) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-invasive Prenatal Paternity Testing(NIPPT) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-invasive Prenatal Paternity Testing(NIPPT) market.

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Company

BGI Genomics

Ultrasound Plus

Roche company

PrenatalGeneticslab

Natera

LabCorp

International Biosciences

Illumina

Express Diagnostic Center (EDC)

EasyDNA

DDC

Axis DNA Labs

AlphaBiolabs

AffinityDNA

Acecgt Group

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Type

Reagents

Service

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Application

Non-legal Paternity Test

Legal Paternity Test

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-invasive Prenatal Paternity Testing(NIPPT) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-invasive Prenatal Paternity Testing(NIPPT) key companies, revenue, market share, and recent developments.

3. To split the Non-invasive Prenatal Paternity Testing(NIPPT) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-invasive Prenatal Paternity Testing(NIPPT) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-invasive Prenatal Paternity Testing(NIPPT) significant trends, drivers, influence factors in global and regions.

6. To analyze Non-invasive Prenatal Paternity Testing(NIPPT) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Prenatal Paternity Testing(NIPPT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Prenatal Paternity Testing(NIPPT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-invasive Prenatal Paternity Testing(NIPPT) industry.

Chapter 3: Detailed analysis of Non-invasive Prenatal Paternity Testing(NIPPT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-invasive Prenatal Paternity Testing(NIPPT) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-invasive Prenatal Paternity Testing(NIPPT) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends Table 2. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Drivers Table 3. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Opportunities and Challenges Table 4. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Restraints Table 5. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Company (2021-2026) Table 7. Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-invasive Prenatal Paternity Testing(NIPPT) Key Company Manufacturing Base & Headquarters Table 9. Global Non-invasive Prenatal Paternity Testing(NIPPT) Company, Product Type & Application Table 10. Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-invasive Prenatal Paternity Testing(NIPPT) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Reagents Table 15. Significant Companies of Service Table 16. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type (2021-2026) Table 20. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Non-legal Paternity Test Table 22. Significant Companies of Legal Paternity Test Table 23. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application (2021-2026) Table 27. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application (2027-2032) Table 28. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Region (2021-2026) Table 31. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Region (2027-2032) Table 33. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Market Share by Country (2021-2026) Table 36. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Market Share by Country (2027-2032) Table 38. BGI Genomics Company Information Table 39. BGI Genomics Business Overview Table 40. BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 42. BGI Genomics Recent Development Table 43. Ultrasound Plus Company Information Table 44. Ultrasound Plus Business Overview Table 45. Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 47. Ultrasound Plus Recent Development Table 48. Roche company Company Information Table 49. Roche company Business Overview Table 50. Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 52. Roche company Recent Development Table 53. PrenatalGeneticslab Company Information Table 54. PrenatalGeneticslab Business Overview Table 55. PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 57. PrenatalGeneticslab Recent Development Table 58. Natera Company Information Table 59. Natera Business Overview Table 60. Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 62. Natera Recent Development Table 63. LabCorp Company Information Table 64. LabCorp Business Overview Table 65. LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 67. LabCorp Recent Development Table 68. International Biosciences Company Information Table 69. International Biosciences Business Overview Table 70. International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 72. International Biosciences Recent Development Table 73. Illumina Company Information Table 74. Illumina Business Overview Table 75. Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 77. Illumina Recent Development Table 78. Express Diagnostic Center (EDC) Company Information Table 79. Express Diagnostic Center (EDC) Business Overview Table 80. Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 82. Express Diagnostic Center (EDC) Recent Development Table 83. EasyDNA Company Information Table 84. EasyDNA Business Overview Table 85. EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 87. EasyDNA Recent Development Table 88. DDC Company Information Table 89. DDC Business Overview Table 90. DDC Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 92. DDC Recent Development Table 93. Axis DNA Labs Company Information Table 94. Axis DNA Labs Business Overview Table 95. Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 97. Axis DNA Labs Recent Development Table 98. AlphaBiolabs Company Information Table 99. AlphaBiolabs Business Overview Table 100. AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 102. AlphaBiolabs Recent Development Table 103. AffinityDNA Company Information Table 104. AffinityDNA Business Overview Table 105. AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 107. AffinityDNA Recent Development Table 108. Acecgt Group Company Information Table 109. Acecgt Group Business Overview Table 110. Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 112. Acecgt Group Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. Non-invasive Prenatal Paternity Testing(NIPPT) Product Image Figure 2. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Reagents Image Figure 8. Service Image Figure 9. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type (2021-2032) Figure 12. Non-legal Paternity Test Image Figure 13. Legal Paternity Test Image Figure 14. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application (2021-2032) Figure 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032) & (US$ Million) Figure 20. North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032) & (US$ Million) Figure 26. South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents
  • Service
Applications
  • Non-legal Paternity Test
  • Legal Paternity Test
Companies covered
  • BGI Genomics
  • Ultrasound Plus
  • Roche company
  • PrenatalGeneticslab
  • Natera
  • LabCorp
  • International Biosciences
  • Illumina
  • Express Diagnostic Center (EDC)
  • EasyDNA
  • DDC
  • Axis DNA Labs
  • AlphaBiolabs
  • AffinityDNA
  • Acecgt Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-invasive Prenatal Paternity Testing(NIPPT) Market Dynamics
  1. 2.1 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends
  2. 2.2 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Drivers
  3. 2.3 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Opportunities and Challenges
  4. 2.4 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Restraints
3 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Company
  1. 3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Revenue Ranking in 2025
  2. 3.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Company (2021-2026)
  3. 3.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Ranking (2024-2026)
  4. 3.4 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Product Type and Application
  6. 3.6 Global Non-invasive Prenatal Paternity Testing(NIPPT) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-invasive Prenatal Paternity Testing(NIPPT) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Type
  1. 4.1 Non-invasive Prenatal Paternity Testing(NIPPT) Type Introduction
  2. 4.1.1 Reagents
  3. 4.1.2 Service
  4. 4.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type
  5. 4.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Type (2021-2032)
  7. 4.2.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type (2021-2032)
5 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Application
  1. 5.1 Non-invasive Prenatal Paternity Testing(NIPPT) Application Introduction
  2. 5.1.1 Non-legal Paternity Test
  3. 5.1.2 Legal Paternity Test
  4. 5.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application
  5. 5.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Application (2021-2032)
  7. 5.2.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application (2021-2032)
6 Non-invasive Prenatal Paternity Testing(NIPPT) Regional Value Analysis
  1. 6.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032)
  7. 6.3.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032)
  10. 6.4.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032)
  16. 6.6.2 South America Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Country, 2025 VS 2032
7 Non-invasive Prenatal Paternity Testing(NIPPT) Country-level Value Analysis
  1. 7.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BGI Genomics
  2. 8.1.1 BGI Genomics Company Information
  3. 8.1.2 BGI Genomics Business Overview
  4. 8.1.3 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  6. 8.1.5 BGI Genomics Recent Developments
  7. 8.2 Ultrasound Plus
  8. 8.2.1 Ultrasound Plus Company Information
  9. 8.2.2 Ultrasound Plus Business Overview
  10. 8.2.3 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  12. 8.2.5 Ultrasound Plus Recent Developments
  13. 8.3 Roche company
  14. 8.3.1 Roche company Company Information
  15. 8.3.2 Roche company Business Overview
  16. 8.3.3 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  18. 8.3.5 Roche company Recent Developments
  19. 8.4 PrenatalGeneticslab
  20. 8.4.1 PrenatalGeneticslab Company Information
  21. 8.4.2 PrenatalGeneticslab Business Overview
  22. 8.4.3 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  24. 8.4.5 PrenatalGeneticslab Recent Developments
  25. 8.5 Natera
  26. 8.5.1 Natera Company Information
  27. 8.5.2 Natera Business Overview
  28. 8.5.3 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  30. 8.5.5 Natera Recent Developments
  31. 8.6 LabCorp
  32. 8.6.1 LabCorp Company Information
  33. 8.6.2 LabCorp Business Overview
  34. 8.6.3 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  36. 8.6.5 LabCorp Recent Developments
  37. 8.7 International Biosciences
  38. 8.7.1 International Biosciences Company Information
  39. 8.7.2 International Biosciences Business Overview
  40. 8.7.3 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  42. 8.7.5 International Biosciences Recent Developments
  43. 8.8 Illumina
  44. 8.8.1 Illumina Company Information
  45. 8.8.2 Illumina Business Overview
  46. 8.8.3 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  48. 8.8.5 Illumina Recent Developments
  49. 8.9 Express Diagnostic Center (EDC)
  50. 8.9.1 Express Diagnostic Center (EDC) Company Information
  51. 8.9.2 Express Diagnostic Center (EDC) Business Overview
  52. 8.9.3 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  54. 8.9.5 Express Diagnostic Center (EDC) Recent Developments
  55. 8.10 EasyDNA
  56. 8.10.1 EasyDNA Company Information
  57. 8.10.2 EasyDNA Business Overview
  58. 8.10.3 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  60. 8.10.5 EasyDNA Recent Developments
  61. 8.11 DDC
  62. 8.11.1 DDC Company Information
  63. 8.11.2 DDC Business Overview
  64. 8.11.3 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  66. 8.11.5 DDC Recent Developments
  67. 8.12 Axis DNA Labs
  68. 8.12.1 Axis DNA Labs Company Information
  69. 8.12.2 Axis DNA Labs Business Overview
  70. 8.12.3 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  72. 8.12.5 Axis DNA Labs Recent Developments
  73. 8.13 AlphaBiolabs
  74. 8.13.1 AlphaBiolabs Company Information
  75. 8.13.2 AlphaBiolabs Business Overview
  76. 8.13.3 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  78. 8.13.5 AlphaBiolabs Recent Developments
  79. 8.14 AffinityDNA
  80. 8.14.1 AffinityDNA Company Information
  81. 8.14.2 AffinityDNA Business Overview
  82. 8.14.3 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  84. 8.14.5 AffinityDNA Recent Developments
  85. 8.15 Acecgt Group
  86. 8.15.1 Acecgt Group Company Information
  87. 8.15.2 Acecgt Group Business Overview
  88. 8.15.3 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  90. 8.15.5 Acecgt Group Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst